Vilnius University Hospital Santaros Klinikos

At Vilnius University Hospital Santaros Klinikos, clinical research is focused on immune system diseases, with particular attention to rare kidney-related inflammatory disorders that affect the glomeruli. The trials are designed to better understand disease behavior and evaluate new treatment options for patients with limited therapeutic choices.

• Studies in C3 glomerulopathy and idiopathic immune complex-mediated glomerulonephritis
• Research aimed at assessing the safety and tolerability of new therapies
• Clinical work exploring how investigational treatments may help improve disease control in rare immune-mediated kidney disease

The site’s research activity in Vilnius reflects a strong focus on advancing care for uncommon nephrology conditions through studies that look at both treatment effects and patient safety.

This research program centers on C3 glomerulopathy, a rare form of glomerular disease linked to immune system dysfunction. The trials are evaluating investigational therapies to see whether they can offer meaningful benefit for patients by improving disease management and supporting better long-term outcomes.

• Testing new treatment approaches for C3G and related glomerulonephritis
• Evaluating how well emerging therapies are tolerated and how safely they can be used
• Studying the potential effects of novel medicines on immune-mediated kidney inflammation

With only a small number of trials underway, the Nephrology center is contributing to focused research on rare diseases that may help shape future treatment options in Lithuania and beyond.